Literature DB >> 29719444

Ductal carcinoma in situ is presumably not a metastatic disease: a reply to "Commentary: Wherein the authors attempt to minimize the confusion generated by their study 'Breast cancer mortality after a diagnosis of ductal carcinoma in situ' by several commentators who disagree with them and a few who don't: a qualitative study".

Brett T Snodgrass1.   

Abstract

Entities:  

Year:  2018        PMID: 29719444      PMCID: PMC5927799          DOI: 10.3747/co.25.3881

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  6 in total

1.  Diagnostic discrepancies in breast specimens subjected to gross reexamination.

Authors:  E L Wiley; P Keh
Journal:  Am J Surg Pathol       Date:  1999-08       Impact factor: 6.394

Review 2.  In-situ breast cancer: the EORTC consensus meeting.

Authors:  J A van Dongen; I S Fentiman; J R Harris; R Holland; J L Peterse; B Salvadori; H J Stewart
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

3.  Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.

Authors:  Steven A Narod; Javaid Iqbal; Vasily Giannakeas; Victoria Sopik; Ping Sun
Journal:  JAMA Oncol       Date:  2015-10       Impact factor: 31.777

4.  Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.

Authors:  Brett Snodgrass
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

5.  Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-Reply.

Authors:  Steven A Narod
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

6.  Wherein the authors attempt to minimize the confusion generated by their study "Breast cancer mortality after a diagnosis of ductal carcinoma in situ" by several commentators who disagree with them and a few who don't: a qualitative study.

Authors:  S A Narod; H Ahmed; V Sopik
Journal:  Curr Oncol       Date:  2017-08-31       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.